Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression of Prostate Cancer”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Testing effectiveness (Phase 2)Looking for participantsNCT06844383
What this trial is testing

Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium 126
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Testing effectiveness (Phase 2)WithdrawnNCT02538432
What this trial is testing

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Who this might be right for
Prostate CancerNon-Small Cell Lung CancerBreast Cancer
University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT00096551
What this trial is testing

A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT01692262
What this trial is testing

Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,+3 more
AstraZeneca 59
Testing effectiveness (Phase 2)Looking for participantsNCT05751941
What this trial is testing

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Study completedNCT00970203
What this trial is testing

Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Who this might be right for
Cancer of ProstateCancer of the ProstateNeoplasms, Prostate+4 more
Roswell Park Cancer Institute 13
Testing effectiveness (Phase 2)UnknownNCT01883128
What this trial is testing

FOcal RECurrent Assessment and Salvage Treatment

Who this might be right for
Progression of Prostate Cancer
University College London Hospitals 177
Testing effectiveness (Phase 2)Study completedNCT05679193
What this trial is testing

Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence

Who this might be right for
Prostate Cancer
Oslo University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00849290
What this trial is testing

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Who this might be right for
Metastatic Androgen Independent Prostate Cancer
Dendreon 113
Early research (Phase 1)Study completedNCT02207504
What this trial is testing

Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 24
Early research (Phase 1)WithdrawnNCT02182622
What this trial is testing

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Who this might be right for
Prostate Cancer
Martin Gutierrez
Not applicableEnded earlyNCT01076751
What this trial is testing

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Prostatic Neoplasms
Sanofi 82
Testing effectiveness (Phase 2)Study completedNCT00659438
What this trial is testing

Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Genzyme, a Sanofi Company 95
Large-scale testing (Phase 3)Study completedNCT02085252
What this trial is testing

The Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer

Who this might be right for
Prostate Cancer
Takeda 116
Large-scale testing (Phase 3)Study completedNCT00027859
What this trial is testing

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05191680
What this trial is testing

TherApeutics in Early ProState Cancer (TAPS02)

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 90
Not applicableUnknownNCT03988686
What this trial is testing

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Who this might be right for
Prostate Cancer Metastatic
Fudan University 120
Load More Results